Generic Mifepristone
Medical termination of intrauterine pregnancy through 70 days gestation
ApprovedActive
Key Facts
Indication
Medical termination of intrauterine pregnancy through 70 days gestation
Phase
Approved
Status
Active
Company
About GenBioPro
GenBioPro is a mission-driven generic pharmaceutical company focused on reproductive health, specifically on improving access to medical abortion care. Its flagship product is the first and only FDA-approved generic version of mifepristone, a key medication used in combination with misoprostol for terminating early pregnancy. The company's strategy combines commercial activity with legal and regulatory advocacy to reshape the accessibility landscape, having successfully advocated for changes to FDA dispensing requirements. GenBioPro positions itself as a stabilizing force for supply and a catalyst for price reduction in a politically and legally volatile market.
View full company profile